MedTrace Logo

Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease

NCT00351156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-08-19

No results posted yet for this study

Summary

The purpose of this study is to learn more about Gaucher disease. The information we collect from medical histories and a blood sample from people with Gaucher disease may help us pinpoint certain things that are different between people who have Gaucher disease and people who do not have Gaucher disease. This information may be useful in the future to help find new treatments for Gaucher disease.

Conditions

  • Gaucher Disease

Interventions

PROCEDURE

Blood sample

Sponsors & Collaborators

  • Amicus Therapeutics

    lead INDUSTRY

Principal Investigators

  • Karin Ludwig, M.D. · Amicus Therapeutics, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00351156 on ClinicalTrials.gov